Search This Blog

Monday, August 26, 2013

Amgen tol buy Onyx for $10.4 billion - Aug. 26, 2013

Looking to get a stronger footing in the cancer drug market, Amgen, the world's largest biopharmaceutical company, has struck a deal to buy Onyx Pharmaceuticals for $10.4 billion.


Amgen tol buy Onyx for $10.4 billion - Aug. 26, 2013

No comments:

Post a Comment